1. A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment. Issue 9 (20th December 2017) Authors: Peverelli, E.; Giardino, E.; Treppiedi, D.; Catalano, R.; Mangili, F.; Locatelli, M.; Lania, A.G.; Arosio, M.; Spada, A.; Mantovani, G. Journal: International journal of cancer Issue: Volume 142:Issue 9(2018) Page Start: 1842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells. (28th October 2018) Authors: Peverelli, E.; Giardino, E.; Mangili, F.; Treppiedi, D.; Catalano, R.; Ferrante, E.; Sala, E.; Locatelli, M.; Lania, A.G.; Arosio, M.; Spada, A.; Mantovani, G. Journal: Cancer letters Issue: Volume 435(2018) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells. (10th October 2017) Authors: Peverelli, E.; Catalano, R.; Giardino, E.; Treppiedi, D.; Morelli, V.; Ronchi, C.L.; Vaczlavik, A.; Fusco, N.; Ferrero, S.; Bertherat, J.; Beuschlein, F.; Chiodini, I.; Arosio, M.; Spada, A.; Mantovani, G. Journal: Cancer letters Issue: Volume 406(2017) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. (15th September 2019) Authors: Giardino, E.; Catalano, R.; Barbieri, A.M.; Treppiedi, D.; Mangili, F.; Spada, A.; Arosio, M.; Mantovani, G.; Peverelli, E. Journal: Molecular and cellular endocrinology Issue: Volume 495(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Detecting precipitation trend using a multiscale approach based on quantile regression over a Mediterranean area. (7th May 2021) Authors: Treppiedi, D.; Cipolla, G.; Francipane, A.; Noto, L.V. Journal: International journal of climatology Issue: Volume 41:Number 13(2021) Page Start: 5938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors. Issue 8 (8th February 2017) Authors: Peverelli, E.; Giardino, E; Treppiedi, D.; Meregalli, M.; Belicchi, M.; Vaira, V.; Corbetta, S.; Verdelli, C.; Verrua, E.; Serban, A. L.; Locatelli, M.; Carrabba, G.; Gaudenzi, G.; Malchiodi, E.; Cassinelli, L.; Lania, A. G.; Ferrero, S.; Bosari, S.; Vitale, G.; Torrente, Y. Journal: International journal of cancer Issue: Volume 140:Issue 8(2017:Apr. 15) Page Start: 1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation. Issue 2 (28th October 2016) Authors: Peverelli, E.; Giardino, E.; Treppiedi, D.; Locatelli, M.; Vaira, V.; Ferrero, S.; Bosari, S.; Lania, A.G.; Spada, A.; Mantovani, G. Journal: Cancer letters Issue: Volume 381:Issue 2(2016) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion. (15th January 2021) Authors: Giardino, E.; Catalano, R.; Mangili, F.; Barbieri, A.M.; Treppiedi, D.; Elli, F.M.; Dolci, A.; Contarino, A.; Spada, A.; Arosio, M.; Mantovani, G.; Peverelli, E. Journal: Molecular and cellular endocrinology Issue: Volume 520(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells. (28th January 2021) Authors: Catalano, R.; Giardino, E.; Treppiedi, D.; Mangili, F.; Morelli, V.; Elli, F.M.; Serban, A.L.; Luconi, M.; Mannelli, M.; Spada, A.; Arosio, M.; Mantovani, G.; Peverelli, E. Journal: Cancer letters Issue: Volume 497(2021) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗